When is hormone therapy recommended for endometrial hyperplasia?

Endometrial hyperplasia means the lining of the womb has become unusually thick. It is not automatically cancer. A biopsy helps identify whether there are atypical or precancerous cell changes and whether cancer is present. Progestogen can counter the effect of oestrogen on the lining, which is why it may be used for hyperplasia. Cancer hormone therapy is a separate treatment category and should not be started simply because the lining is thickened.

Ask the gynaecology team to explain the biopsy wording, whether atypical cells were found, and whether the recommended progestogen will be given as tablets, a hormonal coil, or another form. Keep planned follow-up appointments because repeat sampling may be needed. Discuss fertility plans, bleeding pattern, other medicines, and any condition that could affect treatment. See Endometrial Hyperplasia and Hormone Therapy for Cancer for background.

Seek prompt advice for heavy or prolonged bleeding, dizziness, severe pelvic pain, fever, or unusual discharge. Arrange an earlier review if bleeding continues despite treatment or returns after improving. Urgent assessment is needed for fainting, severe weakness, or bleeding that is difficult to control.

Ask whether the biopsy shows simple hyperplasia, atypical changes, or cancer; what the proposed hormone treatment is intended to do; when the lining will be checked again; and which symptoms should lead to urgent contact.